Skip to main content
The FiscalWire

ALGS

NASDAQ-CM

Aligos Therapeutics, Inc. Common Stock

$4.86
-0.53 (-9.83%)

Key Statistics - ALGS

Valuation Measures

MetricCurrent
Market Cap30.35M
Enterprise Value0
Trailing P/E—
Forward P/E—
PEG Ratio (5yr expected)—
Price/Sales0.96
Price/Book0.95
EV/Revenue—
EV/EBITDA—

Financial Highlights

Fiscal Year

Fiscal Year Ends—
Most Recent Quarter (mrq)—

Profitability

Profit Margin-241.01%
Operating Margin (ttm)-250.63%

Management Effectiveness

Return on Assets (ttm)-75.57%
Return on Equity (ttm)-113.59%

Income Statement

Revenue (ttm)—
Revenue Per Share (ttm)—
Quarterly Revenue Growth (yoy)2778.55%
Gross Profit (ttm)—
EBITDA—
Net Income Avi to Common (ttm)—
Diluted EPS (ttm)-7.31
Quarterly Earnings Growth (yoy)90.59%

Balance Sheet

Total Cash (mrq)—
Total Cash Per Share (mrq)4.87
Total Debt (mrq)—
Total Debt/Equity (mrq)0.11
Current Ratio (mrq)2.19
Book Value Per Share (mrq)5.11

Cash Flow Statement

Operating Cash Flow (ttm)—
Levered Free Cash Flow (ttm)—

Trading Information

Stock Price History

Beta (5Y Monthly)2.41
52 Week Change—
S&P500 52-Week Change—
52 Week High13.69
52 Week Low3.98
50-Day Moving Average0.00
200-Day Moving Average0.00

Share Statistics

Avg Vol (3 month)83.45K
Avg Vol (10 day)0
Shares Outstanding5.44M
Implied Shares Outstanding5.44M
Float4.85M
% Held by Insiders22.29%
% Held by Institutions36.71%
Shares Short—
Short Ratio8.49
Short % of Float14.61%
Short % of Shares Outstanding—
Shares Short (prior month)—

Dividends & Splits

Forward Annual Dividend Rate—
Forward Annual Dividend Yield—
Trailing Annual Dividend Rate—
Trailing Annual Dividend Yield—
5 Year Average Dividend Yield—
Payout Ratio—
Dividend Date—
Ex-Dividend Date—
Last Split Factor—
Last Split Date—